A drug can clear the FDA and still turn out to cause serious harm — because approval rests on what the manufacturer discloses. When a company learns of a risk and doesn't put it on the label, the people who took the drug are the ones who pay for it. These are the drugs currently in litigation.
Most people arrive here knowing their diagnosis, not the name of the product. Type what you were told you have and we'll point you to the right case — across every category.
Don't see yours? Ask us anyway — new litigation opens all the time.
Meningioma (brain tumor)
Who may qualifyPeople who received Depo-Provera contraceptive injections for a year or longer and were later diagnosed with a meningioma.
See if you qualifySevere tooth decay, tooth loss
Who may qualifyUsers of Suboxone sublingual film who suffered significant dental damage, decay or tooth loss after starting treatment.
See if you qualifyGastroparesis, bowel obstruction
Who may qualifyPeople prescribed Ozempic, Wegovy or similar GLP-1 drugs who were diagnosed with stomach paralysis or intestinal blockage.
See if you qualifyVision loss, maculopathy
Who may qualifyLong-term Elmiron users diagnosed with retinal damage or pigmentary maculopathy. Confirm current filing status.
See if you qualifyFDA approval is not a safety guarantee, and it is not a shield. Approval is a judgment made on the evidence the manufacturer submits. If the company knew about a risk and didn't disclose it — or learned about it later and didn't update the warning label — approval doesn't protect them.
Almost every drug case comes down to one question: did the company know, and did it warn? Not whether the drug is dangerous — most useful drugs carry risk. Whether the people taking it were told.
You'll see "MDL" on nearly every case on this page. It means similar federal cases have been grouped before a single judge to handle the shared pretrial work — the same expert witnesses, the same documents, argued once instead of a thousand times.
The critical difference from a class action: you keep your own case. In a class action everyone shares one outcome. In an MDL, your claim is still yours, and what it's worth depends on your own facts — your diagnosis, your exposure, your losses.
Every state sets a filing deadline, and it usually runs from your diagnosis — or from when you reasonably should have connected the diagnosis to the drug. Once it passes, the claim is generally gone, no matter how strong it was. If you're wondering whether to look into it, that's the answer: look into it now.
Do not stop taking a prescribed medication because you read something on this page. Some of these drugs are treating serious conditions, and stopping abruptly can be more dangerous than continuing. Talk to your doctor. A legal claim and your medical care are separate decisions.
That's the normal starting point. Tell us what you took and what happened — we'll tell you whether it matches anything active, and if it doesn't, we'll say so.
The review is free. If we connect you with an attorney, they typically work on contingency — paid from a recovery, if there is one. You are never billed by us. Results are not guaranteed.
Prefer to talk to a person? 888-916-9925